| DC Field | Value | Language |
|---|
| dc.contributor.author | Romaschenko, O. V. | - |
| dc.contributor.author | Pokrovsky, M. V. | - |
| dc.contributor.author | Nadezhdin, S. V. | - |
| dc.contributor.author | Zhernakova, N. I. | - |
| dc.contributor.author | Alferov, P. K. | - |
| dc.date.accessioned | 2023-09-21T13:35:28Z | - |
| dc.date.available | 2023-09-21T13:35:28Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.citation | The cytoprotective property of ethoxidol in patients with coronary heart disease / O.V. Romaschenko [et al.] // HIV Nursing. - 2022. - Vol.22, №2.-P. 69-75. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/56347 | - |
| dc.description.abstract | The widespread prevalence and high mortality rate from coronary heart disease (CHD), despite the accepted treatment standards, aim at finding the most rational drug combinations, expanding the range of drugs, and developing personalized approaches to their use | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | antioxidants (ethoxidol) | ru |
| dc.subject | leukocytes | ru |
| dc.subject | viability | ru |
| dc.subject | coronary heart disease | ru |
| dc.subject | patients | ru |
| dc.subject | microscopy | ru |
| dc.subject | in vitro study | ru |
| dc.subject | personalized pharmacotherapy | ru |
| dc.title | The cytoprotective property of ethoxidol in patients with coronary heart disease | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
